EMGM website back to homepage

List of Posters

Epidemiology of invasive meningococcal, pneumococcal and Haemophilus influenzae disease

P01
Invasive Diseases due to Neisseria meningitidis and Haemophilus Influenzae in Italy, 2015–2016

Paola Stefanelli, Rome, Italy(ID 2)

P02
Invasive meningococcal disease in Poland, 2015–2016

Izabela Waśko, Warsaw, Poland(ID 6)

P03
Distribution of Neisseria meningitidis sequence types in CIS countries

Yulia Urban, Moscow, Russian Federation(ID 9)

P04
The epidemiology of invasive meningococcal disease and vaccination strategy in the Czech Republic

Pavla Krizova, Prague, Czech Republic(ID 15)

P05
Epidemiology of meningococcal disease in Germany

Wiebke Hellenbrand, Berlin, Germany(ID 17)

P06
Epidemiology of invasive meningococcal disease in Finland, 2016

Maija Toropainen, Helsinki, Finland(ID 19)

P07
Why should teenagers and adults in the UK consider protecting themselves against meningococcal serogroup B disease?

Andrew Vyse, Tadworth, Walton Oaks, UK(ID 29)

P08
Invasive meningococcal disease in Sweden 2016

Susanne Jacobsson, Örebro, Sweden(ID 32)

P09
Invasive meningococcal disease in the Netherlands, 2015–2016

Arie van der Ende, Amsterdam, the Netherlands(ID 37)

P10
Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative

Ener Cagri Dinleyici, Eskisehir, Turkey(ID 39)

P11
Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data

Robert Mulhall, Dublin, Ireland(ID 53)

P12
Epidemiology of Invasive Meningococcal Disease in the Republic of Ireland during the epidemiological year 2015/2016

Robert Mulhall, Dublin, Ireland(ID 54)

P13
Epidemiology and surveillance of meningococcal disease in England

Steve Gray, Manchester, UK(ID 65)

P14
Invasive disease caused by Neisseria meningitidis, Croatia January 2015 – May 2017

Suzana Bukovski, Zagreb, Croatia(ID 74)

P15
National increase in meningococcal group C disease, Scotland, 2016

Kevin Scott, Glasgow, UK(ID 75)

P16
Establishment of the Meningitis Research Foundation Meningococcus Genome Library as a keystone of global meningococcal research

Jay Lucidarme, Manchester, UK(ID 81)

P17
Invasive meningococcal disease in Greece: 2 year epidemiological data (2015–2016)

Konstantinos Kesanopoulos, Athens, Greece(ID 82)

P18
Epidemiology of invasive meningococcal disease in Portugal in the last decade – 2007–2016

Maria João Simões, Lisbon, Portugal(ID 89)

P19
Epidemiology of invasive meningococcal disease in university students in England

Sonia Ribeiro, London, UK(ID 90)

P20
Invasive Haemophilus influenzae disease in the Czech Republic in 1999–2016

Vera Lebedova, Prague, Czech Republic(ID 13)

P21
Epidemiology of Haemophilus influenzae invasive disease in Portugal, 2011–2016

Catarina Heliodoro, Lisbon, Portugal(ID 14)

P22
Epidemiology of invasive Haemophilus influenzae disease in Finland, 2016

Maija Toropainen, Helsinki, Finland(ID 20)

P23
Invasive H. influenzae isolates from infants in Germany 2009–2016: laboratory surveillance report

Thien-Tri Lam, Würzburg, Germany(ID 27)

P24
Invasive Haemophilus influenzae population in Poland, 1997–2017

Alicja Kuch, Warsaw, Poland(ID 28)

P25
Invasive Haemophilus influenzae disease in the Netherlands, 2015–2016

Arie van der Ende, Amsterdam, the Netherlands(ID 38)

P26
Croatia – Invasive disease caused by Haemophilus influenzae, January 2015 – May 2017

Suzana Bukovski, Zagreb, Croatia(ID 73)

P27
Haemophilus influenzae Surveillance & Epidemiology in Scotland 2016

Kevin Scott, Glasgow, UK(ID 76)

P28
Haemophilus influenzae in Greece: 14 year of continuous surveillance (2003–2016).

Athanasia Xirogianni, Athens, Greece(ID 78)

P29
Emergence of invasive Haemophilus influenzae serotype a (Hia) disease in England

Sarah Collins, London, UK(ID 85)

P30
Invasive H. influenzae disease in England 15 years after the introduction of the childhood Hib vaccine booster

David Litt, London, UK(ID 87)

P31
Invasive pneumococcal disease before implementation of population-based vaccination in Poland

Anna Skoczynska, Warsaw, Poland(ID 33)

P32
Invasive pneumococcal disease in the Czech Republic in 2016

Jana Kozáková, Prague, Czech Republic(ID 7)

P33
Meningitis due to S. pneumoniae: 6 year epidemiological data in the post PCV-13 vaccination era (2011–2016)

Athanasia Xirogianni, Athens, Greece(ID 79)

P34
Rising incidence of Meningococcal serogroup W disease in Europe 2013–2016

Manuel Krone, Würzburg, Germany(ID 93)

P35
Invasive Meningococcal Disease: surveillance in Casablanca (Morocco)

Aziza Razki, Casablanca, Morocco(ID 95)

P36
Invasive Meningococcal Disease in Russian Federation

Irina Koroleva, Moscow, Russian Federation(ID 96)

P37
Meningococcal disease in eculizumab recipients — United States, 2007–2016

Lucy McNamara, Atlanta, GA, United States(ID 97)

P38
Three Musketeers: Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae and Invasive Bacterial Disease – Croatia 2015–2016

Suzana Bukovski, Zagreb, Croatia(ID 99)

P39
The epidemiology of meningococcal disease in New Zealand 2015–2016

Heather Davies, Porirua, New Zealand(ID 100)

Strain characterization of Neisseria meningitidis and Haemophilus influenzae

P40
Molecular characterization of serogroup B meningococci responsible for IMD in Poland in 2015

Izabela Waśko, Warsaw, Poland(ID 8)

P41
Genomic epidemiology of invasive ET-5 (ST-32cc) Neisseria meningitidis serogroup B isolates in Finland in 1995

Anni Vainio, Helsinki, Finland(ID 23)

(ID 88) P42
Phenotypic characteristics, susceptibility to antimicrobial drugs and molecular characterization of Meningococcus and Haemophilus invasive isolates in Serbia in a seven year period (2009–2016)

Davor Culic, Sombor, Serbia(ID 36)

P43
Whole-genome-based characterization of invasive Haemophilus influenzae isolates from a pre- and post-vaccine era in Portugal

Maria Paula Bajanca-Lavado, Lisbon, Portugal(ID 72)

Laboratory surveillance by molecular techniques of invasive meningococcal and Haemophilus influenzae disease

P44
Molecular surveillance of invasive meningococcal disease in the Czech Republic 2016

Zuzana Vacková, Praha 10, Czech Republic(ID 5)

P45
Whole-genome sequencing (WGS) of Neisseria meningitidis and its potential for use in molecular surveillance of invasive meningococcal disease in the Czech Republic

Michal Honskus, Prague, Czech Republic(ID 12)

P46
Invasive meningococcal diseases and aspect of nasofaryngeal state carrier in Slovakia in a year 2015 and 2016

Anna Kruzlíková, Bratislava, Slovakia(ID 92)

Vaccine implementation and new vaccines

P47
Clonal and antigen gene analysis of MenB vaccine components in invasive Neisseria meningitidis isolates from the Czech Republic, 2007–2016

Martin Musílek, Prague, Czech Republic(ID 11)

P48
Evaluation of coverage of 4CMenB vaccine when administered to infants with different immunization schedules

Alessia Biolchi, Siena, Italy(ID 30)

P49
Investigation of lipoproteins translocation system in Neisseria meningitidis

Maria Giuliani, Siena, Italy(ID 52)

P50
Genetic variability of serogroup B carrier isolates in Greece in the pre- and post-Bexsero® vaccination era

Konstantinos Kesanopoulos, Athens, Greece(ID 80)

P51
Use of saliva to monitor meningococcal vaccine responses: proposing a threshold as surrogate of protection

Guy Berbers, Bilthoven, the Netherlands(ID 91)

P52
Meningococcal strain coverage in the Republic of Ireland in 3 years preceding the introduction of 4CMenB (Bexsero®) into the national infant immunization schedule

Robert Mulhall, Dublin, Ireland(ID 94)

P53
Sustained increase in Accident and Emergency presentations for vaccine reactions in second year post-introduction of the meningococcal B vaccine: an observational study

Neda So, Oxford, UK & Clayton, Australia(ID 98)

Carriage dynamics in meningococci and Haemophilus influenzae

P54
Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis

Laura Cooper, Cambridge, UK(ID 31)

P55
Nasopharyngeal meningococcal carriage rate and serogroup distribution of Turkish citizens lived in Belgium, Germany and the Netherlands during their visit to Turkey

Ener Cagri Dinleyici, Eskisehir, Turkey(ID 40)

P56
Genotypic and phenotypic characterization of the O-linked protein glycosylation system show high glycan diversity in paired meningococcal carriage isolates

Bente Børud, Oslo, Norway(ID 55)

P57
Direct multiplexed digital detection of Neisseria meningitidis gene transcripts from culture and in vivo pharyngeal samples

Yenenesh Tekletsion, Bristol, UK(ID 84)

P58
Pharyngeal carriage of Neisseria meningitidis among undergraduate students of Ahmadu Bello University, Zaria

Shamsudin Aliyu, Zaria, Nigeria(ID 62)